These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 7876402)
1. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers. Freed MI; Audet PR; Zariffa N; Krishna GG; Ilson BE; Everitt DE; Brown LE; Rizzo SM; Nichols AI; Jorkasky DK J Clin Pharmacol; 1994 Nov; 34(11):1098-108. PubMed ID: 7876402 [TBL] [Abstract][Full Text] [Related]
2. Effects of nabumetone, a new non-steroidal anti-inflammatory drug, on urinary prostaglandin excretion in man. Giannessi D; Lazzerini G; Filipponi P; Mannarelli C; Vaiani G; Grossi E; De Caterina R Pharmacol Res; 1993; 28(3):229-41. PubMed ID: 8108313 [TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs and renal response to exercise: a comparison of indomethacin and nabumetone. Olsen NV; Jensen NG; Hansen JM; Christensen NJ; Fogh-Andersen N; Kanstrup IL Clin Sci (Lond); 1999 Oct; 97(4):457-65. PubMed ID: 10491346 [TBL] [Abstract][Full Text] [Related]
4. Sulindac is not renal sparing in man. Roberts DG; Gerber JG; Barnes JS; Zerbe GO; Nies AS Clin Pharmacol Ther; 1985 Sep; 38(3):258-65. PubMed ID: 4028619 [TBL] [Abstract][Full Text] [Related]
5. Renal hemodynamic effects of nabumetone, sulindac, and placebo in patients with osteoarthritis. Cangiano JL; Figueroa J; Palmer R Clin Ther; 1999 Mar; 21(3):503-12. PubMed ID: 10321419 [TBL] [Abstract][Full Text] [Related]
6. Effects of nabumetone on prostanoid biosynthesis in humans. Cipollone F; Ganci A; Panara MR; Greco A; Cuccurullo F; Patrono C; Patrignani P Clin Pharmacol Ther; 1995 Sep; 58(3):335-41. PubMed ID: 7554708 [TBL] [Abstract][Full Text] [Related]
7. Effects of sulindac and indomethacin on renal prostaglandin synthesis. Sedor JR; Williams SL; Chremos AN; Johnson CL; Dunn MJ Clin Pharmacol Ther; 1984 Jul; 36(1):85-91. PubMed ID: 6428794 [TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid effect on arachidonic acid metabolism in vivo. Náray-Fejes-Tóth A; Rosenkranz B; Frölich JC; Fejes-Tóth G J Steroid Biochem; 1988; 30(1-6):155-9. PubMed ID: 3386243 [TBL] [Abstract][Full Text] [Related]
9. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. Stichtenoth DO; Wagner B; Frölich JC J Investig Med; 1997 Feb; 45(2):44-9. PubMed ID: 9084574 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers. van Kraaij DJ; Hovestad-Witterland AH; de Metz M; Vollaard EJ Br J Clin Pharmacol; 2002 Jun; 53(6):644-7. PubMed ID: 12047490 [TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects. Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057 [TBL] [Abstract][Full Text] [Related]
12. The effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function. Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P Br J Rheumatol; 1990 Apr; 29(2):116-9. PubMed ID: 2108782 [TBL] [Abstract][Full Text] [Related]
13. Altered renal and platelet arachidonic acid metabolism in cirrhosis. Laffi G; La Villa G; Pinzani M; Ciabattoni G; Patrignani P; Mannelli M; Cominelli F; Gentilini P Gastroenterology; 1986 Feb; 90(2):274-82. PubMed ID: 3079716 [TBL] [Abstract][Full Text] [Related]
14. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man. Bachi A; Brambilla R; Fanelli R; Bianchi R; Zuccato E; Chiabrando C Br J Pharmacol; 1997 Aug; 121(8):1770-4. PubMed ID: 9283716 [TBL] [Abstract][Full Text] [Related]
15. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis. Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of nabumetone, sulindac, and ibuprofen on renal function. Cook ME; Wallin JD; Thakur VD; Kadowitz PJ; McNamara DB; Garcia MM; Lipani JA; Poland M J Rheumatol; 1997 Jun; 24(6):1137-44. PubMed ID: 9195523 [TBL] [Abstract][Full Text] [Related]
17. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids. Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476 [TBL] [Abstract][Full Text] [Related]
18. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132 [TBL] [Abstract][Full Text] [Related]
19. Sulindac kinetics and effects on renal function and prostaglandin excretion in renal insufficiency. Klassen DK; Stout RL; Spilman PS; Whelton A J Clin Pharmacol; 1989 Nov; 29(11):1037-42. PubMed ID: 2600190 [TBL] [Abstract][Full Text] [Related]
20. Renal hemodynamics and urinary excretion of 6-keto-prostaglandin F1 alpha and thromboxane B2 in newly diagnosed type I diabetic patients. Gambardella S; Andreani D; Cancelli A; Di Mario U; Cardamone I; Stirati G; Cinotti GA; Pugliese F Diabetes; 1988 Aug; 37(8):1044-8. PubMed ID: 3391343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]